Skip to Main Content

Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made is this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Hope you conquer the world and, as always, do keep in touch …

Oregon is the latest state to demand transparency from drug makers, the Washington Examiner notes. Oregon Gov. Kate Brown signed a bill into law that requires drug makers to report the reasons for price increases in their medicines. The companies will have to inform the state when they plan to hike the price of medicines by 10 percent or more, or if the price reaches $100 or more for a one-month supply. The law also requires Oregon’s consumer services department officials to publicly post the list of drugs that face increases and hold public meetings each year about drugs prices.


In a major blow to the effort to pass a federal right-to-try law, House Republicans failed to muster the votes to pass a key compromise measure late Tuesday, STAT reports. The legislation would offer a pathway for patients with a terminal disease to get around Food and Drug Administration rules to request an experimental treatment from a drug maker before the agency has approved the medicine. House Majority Leader Kevin McCarthy of California vowed in a statement after the vote that “the House will not let this be the end.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!